NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 81 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 67.56 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $789,000 | -13.9% | 489,814 | -15.0% | 0.08% | -14.4% |
| Q1 2015 | $916,000 | +2444.4% | 576,276 | +2008.5% | 0.09% | +2900.0% |
| Q3 2014 | $36,000 | -83.3% | 27,331 | -81.3% | 0.00% | -82.4% |
| Q2 2014 | $216,000 | -60.4% | 145,866 | -50.5% | 0.02% | -52.8% |
| Q1 2014 | $545,000 | -37.0% | 294,855 | -29.5% | 0.04% | -12.2% |
| Q4 2013 | $865,000 | – | 418,074 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 15,575,946 | $14,711,000 | 89.51% |
| Financial Advisory Group | 10,000 | $356,000 | 0.17% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 6,704,067 | $6,332,000 | 0.05% |
| LifePlan Financial Group, Inc | 28,810 | $27,000 | 0.02% |
| Greenwich Wealth Management LLC | 65,066 | $61,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 649,880 | $614,000 | 0.01% |
| LYNCH & ASSOCIATES/IN | 18,000 | $17,000 | 0.01% |
| SII INVESTMENTS INC/WI | 90,315 | $86,000 | 0.01% |
| Stratos Wealth Partners, LTD. | 42,535 | $40,000 | 0.00% |
| SVB WEALTH LLC | 46,262 | $44,000 | 0.00% |